Fructophilic Apilactobacillus kunkeei alleviates high-fructose diet-induced lipid accumulation by modulating gut microbiota and intestinal barrier function in mice
Apilactobacillus kunkeei FM01, a fructophilic lactic acid bacterium isolated from honey, shows significant potential as a probiotic for managing metabolic disorders linked to high-fructose diets. The strain effectively reduces lipid accumulation and improves glucose metabolism in mice, while modulating gut microbiota composition. These findings suggest A. kunkeei FM01 could be a valuable candidate for therapeutic applications in metabolic health, warranting further investigation in human populations.
Vitamin B17 alleviates Sorafenib-induced cardiotoxicity in Ehrlich Ascites Carcinoma mice via modulation of inflammatory and fibrotic pathways
Vitamin B17 (VB17) has been shown to alleviate Sorafenib-induced cardiotoxicity in a mouse model of Ehrlich Ascites Carcinoma (EAC) by modulating inflammatory and fibrotic pathways. The study found that the combination therapy significantly reduced tumor volume and improved cardiac function, evidenced by normalized cardiac enzyme levels and reduced oxidative stress markers. Gene expression analysis indicated that VB17 enhances the cardioprotective effects of Sorafenib by regulating key pathways involved in inflammation and apoptosis. These findings suggest a promising strategy for improving the cardiac health of cancer patients undergoing chemotherapy.
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer
本研究探讨了ERCC1在晚期胆道癌患者化疗中的作用，发现高ERCC1表达与患者的总生存率和无进展生存率显著相关，提示其可能作为预后标志物。研究基于日本的JCOG1113临床试验，涉及多家医疗机构，结果为未来胆道癌的治疗提供了重要的生物标志物依据。
Mitigating Chloramphenicol induced liver toxicity by exploring the therapeutic potential of Astaxanthin and Quercetin
本研究探讨了虾青素和槲皮素在减轻氯霉素诱导的肝毒性中的潜力。氯霉素作为一种广谱抗生素，虽有效但其肝毒性限制了临床应用。研究通过评估HepG2细胞中的线粒体毒性，发现这两种抗氧化剂能够显著降低ROS水平并改善线粒体基因表达，显示出其作为潜在治疗剂的应用前景。
M464 inhibits activation of NLRP3 inflammasome and inflammatory response in mice
M464 is a newly synthesized non-steroidal anti-inflammatory drug (NSAID) that releases hydrogen sulfide, demonstrating significant anti-inflammatory effects by inhibiting the NLRP3 inflammasome. In vitro and in vivo studies reveal its potential to protect against acute lung and liver injuries, suggesting it could serve as a promising therapeutic option for inflammatory diseases. The innovative mechanism of action and the results from animal models underscore M464's potential for early-stage investment in the biopharmaceutical sector.
Diabetes reshapes pancreatic cancer-associated endothelial niche by accelerating senescence
本研究揭示糖尿病通过加速内皮细胞衰老重塑胰腺癌相关的内皮微环境，促进肿瘤进展。INHBB被识别为潜在的治疗靶点，Bimagrumab在糖尿病小鼠模型中显示出显著的抗肿瘤效果，提示其在胰腺癌治疗中的应用前景。研究结果为糖尿病患者的个体化治疗提供了新的思路。
MFSD12, transcriptionally regulated by PLAGL2, promotes bladder cancer progression
研究发现MFSD12在膀胱癌中作为重要的致癌基因，其表达在膀胱癌患者中显著升高。通过基因操控实验，MFSD12的敲低抑制了膀胱癌细胞的增殖、迁移和侵袭能力。此外，MFSD12的表达受到转录因子PLAGL2的调控，进一步促进了肿瘤的进展。这些发现表明MFSD12可能成为膀胱癌的新治疗靶点。
Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach
本研究开发了一种针对幽门螺杆菌的多表位疫苗，采用自增强RNA技术，旨在应对该病原体引发的多种胃肠道疾病。研究通过计算免疫信息学方法设计疫苗，选择了五种关键蛋白作为靶点，确保疫苗的广泛免疫覆盖。该疫苗在全球范围内具有潜在的公共卫生影响，尤其是在抗生素耐药性日益严重的地区。
Pancreatic β-cell FFA2 deficiency suppresses multiple low dose streptozotocin induced diabetes in male mice
研究发现，胰腺β细胞FFA2缺失可抑制多次低剂量链脲霉素诱导的糖尿病，FFA2 βKO小鼠的糖尿病发生率显著低于对照组（57%对100%）。FFA2 βKO小鼠表现出更高的β细胞质量和更低的β细胞凋亡，表明FFA2在T1D进展中可能通过调节T1-IFN-SOCS1/3通路发挥作用。这一发现为T1D的早期干预提供了新的潜在靶点，具有重要的临床应用前景。
Development and validation of novel diagnostic recombinant surface antigen D5 and cytotoxic gene pathogenesis island Cag11 protein for Helicobacter pylori
本研究开发了针对幽门螺旋杆菌的新型重组抗原PSA D15和Cag11，并建立了相应的ELISA检测系统。研究结果表明，该系统在检测幽门螺旋杆菌感染方面具有高达93.33%的敏感性和96.67%的特异性，且重复性良好，适合临床应用。该技术的创新性和市场潜力使其成为投资的良好选择，尤其是在非洲等高发地区。
Innovative design and comprehensive characterization of a valine-enhanced lipid nanoparticle-coated mRNA vaccine targeting the SARS-CoV-2 S-RBD antigen
本研究开发了一种新型的mRNA疫苗，针对SARS-CoV-2 S-RBD抗原，采用阳离子脂质纳米颗粒（LNP）进行包裹。研究表明，该疫苗在体外表现出良好的生物相容性和免疫反应，且通过生物信息学分析显示其结构稳定性得到增强。该疫苗的创新设计和全面特征分析为未来的疫苗开发提供了重要的数据支持，具有潜在的市场应用价值。
Explainable artificial intelligence identifies and localizes left ventricular scar in hypertrophic cardiomyopathy using 12-Lead electrocardiogram
XplainScar是一个创新的机器学习模型，专门用于通过12导联心电图检测和定位左心室瘢痕，尤其适用于肥厚型心肌病患者。该模型在两家医院的748名患者中进行训练和验证，显示出高达89%的F1分数和90%的灵敏度。XplainScar的快速分析能力和强大的预测性能使其成为MRI的有效替代方案，具有降低医疗成本和改善患者护理的潜力。
Attention-enhanced hybrid U-Net for prostate cancer grading and explainability
本研究提出了一种新的Transformer注意力混合U-Net架构，旨在提高前列腺癌的分级精度和可解释性。该模型结合了卷积神经网络和Transformer的优点，通过注意力机制和多阶段引导损失机制，显著改善了分割性能。实验结果表明，该模型在Dice Score和IoU等指标上均优于传统U-Net架构，展示了其在临床应用中的潜力。此外，使用可解释人工智能技术（如LIME和Occlusion Sensitivity）验证了模型的决策透明性，增强了临床信任。
Decoding pathogenic MMP9 variants in rheumatoid arthritis using computational and molecular dynamics approaches
本研究通过计算和分子动力学方法分析了MMP9基因的致病性变异，识别了12个关键的非同义单核苷酸多态性（nsSNPs），并探讨了这些变异对蛋白质稳定性和功能的影响。研究结果表明，MMP9在类风湿关节炎的发病机制中发挥重要作用，可能成为未来治疗的靶点。
Prediction of treatment-resistant depression using the 23andMe survey data
本研究开发了一种基于23andMe调查数据的治疗抵抗性抑郁症（TRD）预测模型，利用101个特征进行分析。模型在区分TRD与非抵抗性抑郁症（NTRD）方面表现良好，AUC达到78%。该模型的提出有助于改善抑郁症的管理，能够更早识别TRD患者，从而优化治疗决策。